• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Avacta to Launch SARS-CoV-2 ELISA Laboratory Test americanpharmaceuticalreview
    September 17, 2020
    Avacta, the developer of Affimer® biotherapeutics and reagents, has announced it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19.
  • Avacta to Launch SARS-CoV-2 ELISA Lab Test contractpharma
    September 17, 2020
    To make a high performance Affimer research ELISA test available to support global research efforts to combat the coronavirus.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service